Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis?

Literature DB >> 27976940

Subclinical Interstitial Lung Abnormalities: Toward the Early Detection of Idiopathic Pulmonary Fibrosis?

Athol U Wells^1,2, Maria A Kokosi¹.

Abstract

Entities: Disease

Mesh：

Year: 2016 PMID： 27976940 PMCID： PMC5215035 DOI： 10.1164/rccm.201607-1363ED

Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN： 1073-449X Impact factor: 21.405

× No keyword cloud information.

19 in total

1. Fleischner Society: glossary of terms for thoracic imaging.

Authors: David M Hansell; Alexander A Bankier; Heber MacMahon; Theresa C McLoud; Nestor L Müller; Jacques Remy
Journal: Radiology Date: 2008-01-14 Impact factor: 11.105

2. Interstitial lung abnormalities and reduced exercise capacity.

Authors: Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal: Am J Respir Crit Care Med Date: 2012-01-20 Impact factor: 21.405

3. Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function.

Authors: Carlo Albera; Ulrich Costabel; Elizabeth A Fagan; Marilyn K Glassberg; Eduard Gorina; Lisa Lancaster; David J Lederer; Steven D Nathan; Dominique Spirig; Jeff J Swigris
Journal: Eur Respir J Date: 2016-07-28 Impact factor: 16.671

4. Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS.

Authors: Ulrich Costabel; Yoshikazu Inoue; Luca Richeldi; Harold R Collard; Inga Tschoepe; Susanne Stowasser; Arata Azuma
Journal: Am J Respir Crit Care Med Date: 2016-01-15 Impact factor: 21.405

5. Identification of early interstitial lung disease in smokers from the COPDGene Study.

Authors: George R Washko; David A Lynch; Shin Matsuoka; James C Ross; Shigeaki Umeoka; Alejandro Diaz; Frank C Sciurba; Gary M Hunninghake; Raúl San José Estépar; Edwin K Silverman; Ivan O Rosas; Hiroto Hatabu
Journal: Acad Radiol Date: 2009-09-24 Impact factor: 3.173

6. Galectin-3 Is Associated with Restrictive Lung Disease and Interstitial Lung Abnormalities.

Authors: Jennifer E Ho; Wei Gao; Daniel Levy; Rajalakshmi Santhanakrishnan; Tetsuro Araki; Ivan O Rosas; Hiroto Hatabu; Jeanne C Latourelle; Mizuki Nishino; Josée Dupuis; George R Washko; George T O'Connor; Gary M Hunninghake
Journal: Am J Respir Crit Care Med Date: 2016-07-01 Impact factor: 21.405

7. MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors: Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal: N Engl J Med Date: 2013-05-21 Impact factor: 91.245

8. Early interstitial lung disease in familial pulmonary fibrosis.

Authors: Ivan O Rosas; Ping Ren; Nilo A Avila; Catherine K Chow; Teri J Franks; William D Travis; J Philip McCoy; Rose M May; Hai-Ping Wu; Dao M Nguyen; Mauricio Arcos-Burgos; Sandra D MacDonald; Bernadette R Gochuico
Journal: Am J Respir Crit Care Med Date: 2007-07-19 Impact factor: 21.405

9. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.

Authors: Gong Yong Jin; David Lynch; Ashish Chawla; Kavita Garg; Martin C Tammemagi; Hakan Sahin; Shigeki Misumi; Keun Sang Kwon
Journal: Radiology Date: 2013-03-19 Impact factor: 11.105

10. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study.

Authors: Tetsuro Araki; Rachel K Putman; Hiroto Hatabu; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; David A Schwartz; Ivan O Rosas; George R Washko; George T O'Connor; Gary M Hunninghake
Journal: Am J Respir Crit Care Med Date: 2016-12-15 Impact factor: 21.405

7 in total

1. Update in Interstitial Lung Disease 2016.

Authors: Athol U Wells; Toby M Maher
Journal: Am J Respir Crit Care Med Date: 2017-07-15 Impact factor: 21.405

Review 2. Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis.

Authors: Gary M Hunninghake
Journal: Thorax Date: 2019-02-05 Impact factor: 9.139

Review 3. Predictors of progression in systemic sclerosis patients with interstitial lung disease.

Authors: Oliver Distler; Shervin Assassi; Vincent Cottin; Maurizio Cutolo; Sonye K Danoff; Christopher P Denton; Jörg H W Distler; Anna-Maria Hoffmann-Vold; Sindhu R Johnson; Ulf Müller Ladner; Vanessa Smith; Elizabeth R Volkmann; Toby M Maher
Journal: Eur Respir J Date: 2020-05-14 Impact factor: 16.671

4. Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study.

Authors: Katerina Antoniou; Katerina Markopoulou; Argyrios Tzouvelekis; Athina Trachalaki; Eirini Vasarmidi; Jiannis Organtzis; Vasilios Tzilas; Evangelos Bouros; Georgia Kounti; Christina Rampiadou; Serafeim-Chrysovalantis Kotoulas; Fotini Bardaka; Eleni Bibaki; Evangelia Fouka; Georgios Meletis; Stavros Tryfon; Zoe Daniil; Despina Papakosta; Demosthenes Bouros
Journal: ERJ Open Res Date: 2020-01-27